Published : 05 Dec 2011
Aagami has organized a 10 days partnering trip for CEO and CSO of its German client that have Protein Therapeutic new class of molecules in development.
During this trip we planned to meet 7 top notch Biotech companies of India from Mumbai, Ahmedabad, Pune and Bengaluru. These Indian companies are have own discovery programs and would like to enhance it by partnering with Germany company. These molecules belong to completely new class of proteins, which mimic the naturally occurring Lipocalins in human body.
They have been discovered first by Munich Technology University and have been developed over last 10 years in this Munich area Biotech firm, that have already several specific development projects with 4 major biotechs of US, Europe and Japan.